EP262 Drug Shows No Benefit Over Placebo for Chronic Hives Patients
A recent study concluded that the drug EP262 did not outperform a placebo in treating chronic hives symptoms.
A recent study concluded that the drug EP262 did not outperform a placebo in treating chronic hives symptoms.
Leaders from South Africa, Kenya, and China received accolades at the Global Colorectal Cancer Congress in Nairobi.
Manipal Hospitals promoted the BE FAST initiative for stroke detection during an event in Kolkata, urging quick identification of symptoms.
Recent findings assess how endovascular thrombectomy performs in clinical practice for patients with large ischemic strokes.
Artificial intelligence can significantly improve early detection of tuberculosis and lung cancer, according to Dr. Randeep Guleria.
Tuberculosis remains a significant global health threat, with millions affected and calls for innovative solutions to combat the disease.
A 93-year-old woman was misdiagnosed with sarcoma before invasive melanoma was confirmed, highlighting diagnostic difficulties.
Scientists at the University of Warwick found that a warmth sensor in nerve endings also triggers chronic pain signals, suggesting new treatment…
Amaravati, February 16: Bill Gates, the founder of the Gates Foundation, is set to arrive in Andhra Pradesh today. He will be…
New Delhi, August 22 (Udaipur Kiran): The Indian government is planning to increase the insurance coverage under the Ayushman Bharat scheme. It…